Hope Foundation announces Goodman for Inaugural Meyskens Lecture
The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, has recently established the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention
2024-02-16
(Press-News.org)
The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, has recently established the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention. Since the early 1980’s, Dr. Meyskens has been a leader in the recognition, development, and clinical usage of Prevention in the management of cancer. Frank and Linda have directed the development of this lectureship to advance the explosion of knowledge that is expanding opportunities to engage Prevention in personalized medicine, including early detection and genetically focused treatment options.
The annual lectureship will debut on April 4 at the spring SWOG meeting in Seattle, WA, with inaugural speaker Gary Goodman, MD. Dr. Goodman received his medical oncology training at the University of Arizona and was introduced by Dr. Meyskens to the new field of cancer chemoprevention. Under the mentorship of Dr. Meyskens and working in the lab of Dr. David Alberts, he studied the pharmakinetics and chemopreventive potential of retinoids. Later, after relocating to Seattle as a medical oncologist at Swedish Hospital, Goodman also joined the Fred Hutchinson Cancer Research Center to pilot a cancer chemoprevention trial as part of the recently funded NCI initiative of Cancer Control Research Units. He designed, organized, and later became the principal investigator (PI) of the landmark Beta-Carotene and Retinol Efficacy Trial (CARET). This was a randomized double-blinded trial testing the efficacy of high-dose beta-carotene and retinol for lung cancer prevention in heavy smokers, former heavy smokers, and asbestos-exposed workers.
Dr. Meyskens led one of the CARET Centers at UC Irvine and remained a co-investigator. Although the trial was halted early because the intervention was causally related to increased lung cancer risk, CARET remains a stalwart trial in terms of its design and execution, and it resulted in the reevaluation of vitamins as pharmacologic agents. Dr. Goodman was also co-chair of SWOG’s prevention and epidemiology committee for many years and served as PI of the NCI Community Oncology Research Program (NCORP) site at Swedish Medical Center in Seattle.
Nominations for the Meyskens Lectureship will be solicited each fall, with a review committee comprising leaders from across SWOG’s NCORP committees selecting one speaker for each spring group meeting. Thanks to the generosity of the Meyskens family, and with support from The Hope Foundation, the lectureship will provide all travel and accommodations for each selected speaker to attend and present.
According to Dr. Meyskens, “Linda and I chose to create this lectureship as one of our major philanthropic gifts because SWOG has been so important in allowing not only me, but many others interested in the field of Cancer Prevention, to pursue a variety of new initiatives, many before their time. We are very pleased that Dr. Goodman, who has devoted much of his career to advancing this area, will be presenting the inaugural lecture in this important field.”
“Monumental advances in the field of Cancer Prevention are a direct result of clinical trials and of the great minds who drive progress in preventing disease, alongside those who make strides in treating it. This critical area of study was championed within SWOG’s network by Dr. Meyskens, and then by Dr. Goodman. It’s an ideal pairing to celebrate the launch of this fantastic lectureship,” said Johanna Horn, President & CEO of The Hope Foundation.
SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has 20,000 members in 45 states and nine other countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have directly led to the approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life. Learn more at swog.org, and follow us on Twitter (X) at @SWOG.
The Hope Foundation for Cancer Research is the non-profit charitable arm of SWOG Cancer Research Network. Founded in 1993 to support network members and their work, The Hope Foundation funds clinical and translational research, fellowships, training events, physician education, and patient advocacy. Learn more at thehopefoundation.org, and find us on Twitter (X) and Facebook at @SupportingSWOG.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-02-16
A female White-eared opossum (Didelphis albiventris) found dead in 2021 in Bosque dos Jequitibás Park in the center of Campinas, one of the largest cities in São Paulo state, Brazil, died from rabies meningoencephalitis, according to a group of researchers at the University of São Paulo (USP) and Adolfo Lutz Institute (IAL), the regional reference laboratory, working with health professionals affiliated with public institutions in São Paulo city and Campinas.
Reported in an article published in the journal Emerging Infectious Diseases, the finding serves as an alert to the presence of the virus, which is deadly to humans, ...
2024-02-16
Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis (ALS).
In a new study, researchers discovered a new way to enhance the body’s antioxidant response, which is crucial for cellular protection against the oxidative stress implicated in many neurodegenerative diseases.
The study published today (Feb. 16) in the journal Advanced Materials.
Nathan Gianneschi, the Jacob & Rosaline Cohn Professor of Chemistry at Northwestern’s Weinberg ...
2024-02-16
(Santa Barbara, Calif.) — Anoxic marine basins may be among the most viable places to conduct large-scale carbon sequestration in the deep ocean, while minimizing negative impacts to marine life. So say UC Santa Barbara researchers in a paper published in the journal AGU Advances. As we explore ways to actively draw down the levels of carbon in the atmosphere, sending plant biomass to these barren, oxygen-free zones on the seafloor becomes an option worth considering.
“The big picture here is that all the best models that we have say that we have to do some form of net negative CO2 removal in order to hit climate goals,” said geochemist, geobiologist ...
2024-02-16
Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins the FDA decision.
FDA has approved omalizumab for the reduction of allergic reactions, including anaphylaxis, that may occur with an accidental exposure to one or more foods in adults and children aged 1 year and older with food allergy. People taking omalizumab still need to avoid exposure to foods to which they are allergic. Omalizumab previously received FDA approval ...
2024-02-16
TAMPA, Fla. — Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis, especially in advanced stages. Because of its rarity, few studies focus on better understanding and managing this disease. In a new article published in the Journal of the National Cancer Institute, Moffitt Cancer Center researchers share data on the efficacy and safety of neoadjuvant chemotherapy for locally advanced penile squamous cell carcinoma, addressing a critical gap in evidence regarding treatment options for this rare and aggressive cancer.
The Moffitt team, in collaboration with institutions across ...
2024-02-16
A new paper led by Harvard researchers has zeroed in on biomarkers of aging using omic data from population-based studies. The team, which included aging and longevity expert Alex Zhavoronkov, PhD, founder and CEO of AI-driven drug discovery company Insilico Medicine, provided a framework for standardizing the development and validation of biomarkers of aging to better predict longevity and quality of life. The findings appeared in Nature Medicine.
Biomarkers are biological characteristics that can be measured and used to evaluate various biological processes, ...
2024-02-16
Although primary open-angle glaucoma (POAG) is the leading cause of blindness in people over the age of 55, there remains no cure for the disease and its biological mechanisms are not well understood. Elevated intraocular pressure (IOP) is a major risk factor for the disease, but many patients with glaucoma have normal eye pressure and still lose vision.
In a new study published this past month in Nature Communications, researchers from Mass Eye and Ear, led by Ayellet Segrè, PhD, conducted a comprehensive study that combined genetic discoveries from a large cross-ancestry genome-wide association study meta-analysis of POAG, led by Janey Wiggs, MD, PhD, ...
2024-02-16
LAWRENCE — No one can do everything. Yet that is exactly what many school leaders feel like they must do. A new book from a pair of school leaders and scholars aims to help those who often feel overwhelmed focus on what they can and should do and how to help teachers and students lead schools to reaching their full potential.
“Focused: Understanding, Negotiating, and Maximizing Your Influence as a School Leader,” by Jim Watterston and Yong Zhao, aims to help educational administrators guide schools to success without getting ...
2024-02-16
Testing wastewater to assess the spread of the COVID-19 virus became common and well-publicized during the pandemic, but it has been focused mostly on urban areas.
The Appalachian Regional Commission (ARC) has awarded $400,000 to Virginia Tech, with an additional $50,000 to Virginia Tech from the Virginia Department of Health, for a two-year project to identify and implement improved and new methods to detect pathogens for multiple diseases in the wastewater of rural communities.
“My work and research have primarily been focused on rural areas, and prior to the pandemic, most ...
2024-02-16
The efficiency of oxygen supply to tissues is a factor in the severity of important diseases such as Covid-19 and heart conditions.
Scientists already know that the relationship between the length of a person’s index and ring fingers, known as the 2D:4D ratio is correlated with performance in distance running, age at heart attack and severity of Covid-19.
Now Swansea University digit ratio expert Professor John Manning has been working with colleagues to look more closely at the subject.
Their findings have just been published by the prestigious American Journal of Human ...
LAST 30 PRESS RELEASES:
[Press-News.org] Hope Foundation announces Goodman for Inaugural Meyskens Lecture
The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, has recently established the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention
